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Summary
Objectives:  To  study  the  morbidity  of  central  compartment  dissection  in  differentiated  thyroid
carcinoma  of  the  follicular  epithelium.
Material  and  method:  A  retrospective  study  of  83  patients  (61  patients  operated  by  total
thyroidectomy  and  22  patients  operated  by  total  thyroidectomy  and  central  dissection)  was
performed. Postoperative  serum  calcium  and  laryngeal  mobility  were  studied  and  statistically
compared  (Chi2 test,  Fisher’s  exact  test).
Results:  No  signiﬁcant  difference  was  observed  between  the  two  groups  in  terms  of  the  inci-
dence of  recurrent  laryngeal  nerve  paralysis  or  permanent  hypoparathyroidism.  In  contrast,
transient  hypoparathyroidism  was  more  frequent  among  patients  undergoing  thyroidectomy
associated  with  central  dissection  (P  =  0.02).
Conclusion:  Central  compartment  dissection  associated  with  total  thyroidectomy  does  not
increase  the  risk  of  recurrent  laryngeal  nerve  paralysis  or  permanent  hypoparathyroidism,  but
is responsible  for  an  increased  rate  of  transient  hypoparathyroidism.
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Introduction
Differentiated  thyroid  carcinoma  of  the  follicular  epithe-
lium  is  the  most  common  endocrine  cancer  (5000  new  cases
per  year  in  France)  [1].  The  incidence  of  this  tumour  has
increased  as  a  result  of  earlier  diagnosis  and  changing  clini-
cal  practice  (extension  of  the  indications  for  thyroid  surgery,
improved  histological  diagnosis)  [1].
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French,  European  and  Americans  guidelines  on  thyroid
arcinoma  are  relatively  consensual,  except  for  certain
spects,  especially  the  indications  for  prophylactic  central
ompartment  dissection  for  stage  T1  or  T2  papillary  carci-
oma  [1—4].
This  study  was  designed  to  evaluate  the  morbidity  of
entral  compartment  dissection  in  order  to  clarify  the  con-
roversial  indications  for  this  type  of  lymph  node  dissection.opulation and method
his  retrospective  study  was  based  on  an  11-year  period
January  1998  to  November  2009).
served.
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opulation
ighty-three  patients  (46  women  and  37  men)  with  a  mean
ge  of  51  years  (standard  deviation:  14.1)  were  included  in
his  study.
ethod
nclusion  criteria  were  as  follows:
 patients  of  any  age  and  gender;
 patients  with  thyroid  carcinoma  of  the  follicular  epithe-
lium;
 patients  operated  by  total  thyroidectomy;
 patients  operated  by  total  thyroidectomy  associated  with
central  compartment  (level  VI)  lymph  node  dissection.
Patients  treated  by  subtotal  thyroidectomy  or  lobo-
sthmectomy  were  excluded  from  the  study.
Preoperative  assessment  for  all  patients  consisted  of:
 thyroid  hormone  assays:  TSH,  T3,  T4;
 thyroid  ultrasound.
Some  patients  were  assessed  by:
 contrast-enhanced  neck  and  chest  CT  scan;
 ultrasound-guided  ﬁne-needle  aspiration  cytology  of  sus-
picious  nodules,  essentially  after  2001.
All  patients  were  operated  by  total  thyroidectomy  with
rozen  section  histological  examination  and  all  operations
ere  performed  by  experienced  surgeons.  The  lymph  node
urgical  strategy  was  decided  on  the  basis  of  imaging  ﬁndings
nd  frozen  section  histological  examination  results.
urgical  modalities
ll  patients  were  operated  by  total  thyroidectomy  via
 small  neck  incision.  Sternotomy  was  never  required.
hyroidectomy  was  always  performed  by  capsular  dissec-
ion,  with  identiﬁcation  and  anatomical  preservation  of
he  recurrent  laryngeal  nerve.  In  the  event  of  accidental
arathyroidectomy,  the  parathyroid  glands  concerned  were
eimplanted  in  the  sternocleidomastoid  muscle  in  two  or
hree  sites  after  fragmentation  of  the  glands.
Central  compartment  or  level  VI  lymph  node  dissec-
ion  consisted  of  resection  of  all  adipose  connective  tissue
etween  the  hyoid  bone  superiorly,  the  brachiocephalic
ein,  the  jugular  and  carotid  vascular  fascia  laterally,  the
esophagus  posteriorly,  and  the  prelaryngeal  muscles  ante-
iorly,  with  preservation  of  the  recurrent  laryngeal  nerves
nd  parathyroid  glands.
aryngoscopic  surveillancendirect  laryngoscopy  was  systematically  performed  postop-
ratively  before  the  patient’s  discharge  from  hospital  and
gain  on  the  thirtieth  postoperative  day,  even  in  the  absence
f  voice  disorders.
N
g
pP.  Boute  et  al.
Persistent  hoarseness  related  to  recurrent  laryngeal
erve  paralysis  after  1  year  was  considered  to  be  perma-
ent.  All  patients  with  recurrent  laryngeal  nerve  paralysis
ere  treated  by  early  speech  therapy.
Cases  of  preoperative  recurrent  laryngeal  nerve  paralysis
r  resulting  from  sacriﬁce  of  the  recurrent  laryngeal  nerve
or  oncological  reasons  were  classiﬁed  as  sequelae  rather
han  complications.
urveillance  of  serum  calcium
ypoparathyroidism  was  considered  to  be  present  whenever
alcium  and  vitamin  D  replacement  therapy  was  necessary
o  obtain  corrected  serum  calcium  higher  than  2  mmol/L.
ypoparathyroidism  was  considered  to  be  permanent  when
alcium  and  vitamin  D  replacement  therapy  was  necessary
or  more  than  1  year.  Corrected  serum  calcium  assays  were
erformed  on  D1,  D2,  D3,  and  D10  and  speciﬁc  follow-up
as  then  instituted  in  the  presence  of  any  abnormalities.
tatistical  analysis
tatistical  analysis  was  performed  by  means  of  Chi2 test  or
isher’s  exact  text,  as  appropriate.  P  values  less  than  0.05
ere  considered  signiﬁcant.
esults
umour  characteristics
eventy-six  patients  (91.6%)  had  a  papillary  carcinoma  and
even  patients  (8.4%)  had  a  follicular  carcinoma.  Patients
ere  classiﬁed  into  four  stages  according  to  the  UICC  clas-
iﬁcation:
 45  patients  (54.2%  of  cases)  were  classiﬁed  as  stage  I;
 six  patients  (7.2%  of  cases)  were  classiﬁed  as  stage  II;
 10  patients  (12.1%  of  cases)  were  classiﬁed  as  stage  III;
 22  patients  (26.5%  of  cases)  were  classiﬁed  as  stage  IV.
Sixty-one  patients  (73.5%)  underwent  level  VI  lymph  node
issection.
A  two-stage  surgical  strategy  (completion  thyroidec-
omy)  was  necessary  for  18  patients  (21.7%  of  cases),  but
o  secondary  recurrent  laryngeal  dissection  was  performed.
hirty-six  patients  (43.4%  of  cases)  had  a  papillary  micro-
arcinoma  and  29  patients  (35%  of  cases)  had  a  multifocal
ancer.  Twenty-seven  patients  (44%  of  cases)  presented  signs
f  lymph  node  invasion.  Two  (16.7%)  of  the  12  patients  with  a
icrocarcinoma  less  than  5  mm  in  diameter  presented  level
I  lymphadenopathy,  while  14  (58.3%)  of  the  24  patients  with
 microcarcinoma  more  than  5  mm  in  diameter  presented
evel  VI  lymphadenopathy.  Level  VI  lymph  node  dissection
as  not  performed  in  nine  of  these  36  patients.
ostoperative  recurrent  laryngeal  nerve  paralysisine  patients  (10.8%)  presented  transient  recurrent  laryn-
eal  nerve  paralysis  and  three  patients  (3.6%)  presented
ermanent  recurrent  laryngeal  nerve  paralysis.  One  patient
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Table  1  Postoperative  complications.
Number  Percentage
Transient  RLNP  9  10.8
Permanent  RLNP  3  3.6
Transient  hypoparathyroidism  28  33.7
Permanent  hypoparathyroidism  6  7.2
Haematoma  1  1.2
Operative  site  infection  2  2.4
Keloid scar 2  2.4
Bilateral  RLNP 1  1.2
Pneumonia  1  1.2
Death due  to  postoperative
cardiorespiratory  arrest
1  1.2
Table  2  Comparison  of  complications  between  total  thy-
roidectomy  (TT)  and  thyroidectomy  with  level  VI  lymph  node
dissection  (TT  +  VI  group).
TT
(group
A)
TT  +  VI
(group
B)
P
Transient  RLNP 3  6  0.693b
Permanent  RLNP 1  2  0.669b
Transient
hypoparathyroidism
3  25  0.02a
Permanent
hypoparathyroidism
2  4  0.653b
RLNP: recurrent laryngeal nerve paralysis
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RLNP: recurrent laryngeal nerve paralysis
presented  bilateral  recurrent  laryngeal  nerve  paralysis,
which  was  only  transient  on  one  side.  Tracheotomy  was  not
required.
Postoperative  hypoparathyroidism
Twenty-eight  patients  (33.7%)  presented  transient
hypoparathyroidism  and  six  patients  (7.2%)  presented
permanent  hypoparathyroidism.
Other  complications
Other  complications  are  listed  in  Table  1.
Statistical  analysis
Patients  were  divided  into  two  groups:
•  group  A:  total  thyroidectomy  only  (22  patients);
•  group  B:  total  thyroidectomy  with  central  compartment
dissection  (61  patients).
No  statistically  signiﬁcant  difference  was  observed
between  the  two  groups  in  terms  of  recurrent  laryngeal
nerve  paralysis  (transient  or  permanent)  or  permanent
hypoparathyroidism.  In  contrast,  transient  hypoparathy-
roidism  was  signiﬁcantly  more  frequent  in  group  B  (P  =  0.02)
(Table  2).
Discussion
Recurrent  laryngeal  nerve  paralysis
According  to  the  literature,  the  incidence  of  transient  recur-
rent  laryngeal  nerve  paralysis  after  total  thyroidectomy  for
thyroid  cancer  is  1  to  10%.  In  1  to  5.6%  of  cases,  recurrent
laryngeal  nerve  paralysis  is  permanent  [1,5,6].  Our  results,
based  on  a  relatively  small  series,  conﬁrm  these  data.  Fur-
thermore,  as  demonstrated  by  Chisholm  et  al.  [5],  level  VI
lymph  node  dissection  associated  with  total  thyroidectomy
s
p
t
sa Chi2 test.
b Fisher’s exact test.
oes  not  appear  to  have  any  impact  on  the  incidence  of
ecurrent  laryngeal  nerve  paralysis.
ransient  hypoparathyroidism
he  incidence  of  transient  hypoparathyroidism  varies  con-
iderably  from  one  series  to  another,  ranging  from  3  to  83%
1,5,7,8].
The  results  of  the  present  study  (33.7%  of  transient
ypoparathyroidism)  are  also  consistent  with  those  reported
n  the  literature,  situated  in  the  middle  of  the  range.  Central
ompartment  (level  VI)  lymph  node  dissection  was  associ-
ted  with  a  higher  rate  of  transient  hypoparathyroidism  than
hat  observed  after  total  thyroidectomy  alone  (P  =  0.02),
onﬁrming  the  data  reported  by  Chisholm  et  al.  [5].
This  transient  hypoparathyroidism  can  be  essentially
xplained  by  extension  of  thyroid  dissection  causing  micro-
copic  vascular  lesions  altering  the  quality  of  the  blood
upply  to  the  parathyroid  glands  [1,9,10], rather  than  acci-
ental  parathyroidectomy,  which  does  not  appear  to  be
ore  frequent  in  the  case  of  level  VI  lymph  node  dissection
nd  which,  moreover,  generally  does  not  have  any  impact
n  serum  calcium  [11].
ermanent  hypoparathyroidism
he  incidence  of  permanent  hypoparathyroidism  after  total
hyroidectomy  (for  thyroid  cancer  or  other  indications)
eported  in  the  literature  ranges  from  0  to  29%  of  cases
1,5,7,8].  The  ﬁndings  in  our  series  were  consistent  with
hose  of  the  literature  with  7.2%  of  cases.  However,  this
road  range  of  ﬁgures  is  essentially  related  to  the  time
nterval  used  to  deﬁne  permanent  hypoparathyroidism,  as
his  period  can  vary  from  6  months  to  2  years,  while  cases
f  recovery  have  been  reported  even  after  2  years  [11].
evertheless,  although  the  symptoms  related  to  permanent
ypoparathyroidism  may  appear  to  be  more  acceptable  in
erms  of  the  patient’s  quality  of  life  than  the  voice  and/or
wallowing  disorders  related  to  recurrent  laryngeal  nerve
aralysis,  permanent  hypoparathyroidism  can  be  difﬁcult
o  treat  and  may  require  life-long  calcium  and  vitamin  D
upplements.
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alue  of  level  VI  lymph  node  dissection
entral  compartment  (level  VI)  dissection  is  indicated  in
ifferentiated  thyroid  carcinoma  of  the  follicular  epithe-
ium  with  the  presence  of  level  VI  lymph  nodes,  especially
hen  they  are  suspicious,  demonstrated  on  imaging  or  intra-
peratively.
Prophylactic  central  compartment  dissection  is  systemat-
cally  indicated  in  stage  T2,  T3  or  T4  differentiated  thyroid
arcinoma  of  the  follicular  epithelium,  based  on  T  stage
etermined  on  frozen  section  examination  or  suspected  pre-
peratively  by  positive  ﬁne-needle  aspiration  cytology  and
maging  (neck  and  chest  ultrasound  or  CT).
In  contrast,  no  consensus  has  been  reached  concern-
ng  the  indications  for  prophylactic  central  compartment
issection  in  stage  T1  N0  differentiated  thyroid  carcinoma
f  the  follicular  epithelium,  particularly  microcarcinomas
<  10  mm).
The  essential  question  to  be  resolved  is  whether
esection  of  lymph  nodes  with  a  normal  appearance  at  thy-
oidectomy  is  clinically  useful  and  whether  it  is  associated
ith  a  favourable  beneﬁt/risk  balance  for  the  patient.
The  rationale  for  prophylactic  lymph  node  dissection  is
ased  on  the  suspicion  of  a  high  incidence  of  occult  lymph
ode  metastases,  often  microscopic,  even  in  the  context
f  papillary  microcarcinoma  [12].  However,  the  decision  to
erform  prophylactic  central  compartment  dissection  can-
ot  be  justiﬁed  exclusively  on  the  discovery  of  subclinical
ymph  node  metastases,  but  must  be  based  on  a  demon-
trated  beneﬁt  for  the  patient,  i.e.  in  terms  of  recurrence
r  survival.  However,  evidence  in  favour  of  a  reduction
f  mortality  following  central  compartment  dissection  has
nly  been  reported  in  two  studies  and  remains  controversial
13,14],  as  other  studies  have  reported  contradictory  results
15—17].
Furthermore,  the  apparent  discordance  between  the  rel-
tively  high  rate  of  occult  lymph  node  metastases  detected
n  prophylactic  central  compartment  dissection  and  the
elatively  low  recurrence  rate  after  total  thyroidectomy
ithout  lymph  node  dissection  could  be  correlated  with
djuvant  radioiodine  therapy.
In  conclusion,  arguments  in  favour  of  prophylactic  central
ompartment  dissection  could  be  as  follows:
 the  high  rate  of  cervical  lymph  node  metastases,  espe-
cially  in  papillary  thyroid  carcinoma  (20  to  50%  of  cases);
micrometastases  appear  to  be  even  more  frequent  (up  to
90%  of  cases)  [3];
 preoperative  and  intraoperative  ﬁndings  are  not  always
sufﬁcient  to  conﬁrm  the  diagnosis  of  lymph  node  metas-
tases  [18—20];
 systematic  central  compartment  dissection  associated
with  total  thyroidectomy  for  thyroid  carcinoma  of  the
follicular  epithelium  does  not  increase  the  permanent
complication  rate  of  total  thyroidectomy,  in  contrast  with
central  compartment  dissection  performed  secondarily
after  total  thyroidectomy,  which  is  associated  with  much
higher  morbidity  [6,20—24];
 central  compartment  dissection  allows  precise  staging
of  the  cancer,  allowing  the  patient  to  be  classiﬁed  as
N0/N1,  which  is  a  major  element  to  guide  treatment,P.  Boute  et  al.
particularly  for  the  indications  for  adjuvant  radioiodine
therapy  [25,26];
 lymph  node  dissection  would  have  a  beneﬁcial  impact
on  ‘‘subsequent  events’’,  especially  a lower  local  recur-
rence  rate  [10,15,16,20,27]. In  contrast,  the  presence  of
lymph  node  metastases  does  not  appear  to  alter  survival,
[15—17],  except  for  patients  over  the  age  of  45  years
[13,14,25,28].
Finally,  the  arguments  against  prophylactic  central
ompartment  dissection  are  essentially  the  absence  of  ran-
omized  prospective  trials  indicating  the  beneﬁts  of  this
urgery  for  patients  with  T1  N0  cancer  in  terms  of  improve-
ent  of  the  recurrence  rate  or  survival.  Furthermore,  the
ublished  studies  that  reported  a  gain  in  terms  of  recur-
ence  rate  did  not  clearly  distinguish  between  therapeutic
nd  prophylactic  lymph  node  dissections.  There  is  therefore
o  formal  evidence  of  the  value  of  these  procedures.
onclusion
his  study  conﬁrms  the  absence  of  any  additional  permanent
orbidity  of  central  compartment  dissection  associated
ith  total  thyroidectomy.  This  ﬁnding,  together  with  demon-
tration  of  the  extremely  lymphophilic  nature  of  thyroid
arcinoma  of  the  follicular  epithelium  (especially  papil-
ary  cancers  and  even  microcarcinomas),  could  encourage  a
ore  aggressive  approach  by  proposing  systematic  prophy-
actic  central  compartment  dissection  whenever  possible
positive  frozen  section  examination  demonstrating  stage
1  papillary  carcinoma).  This  approach  may  be  justiﬁed  to
revent  local  recurrence,  although  it  does  not  appear  to
mprove  overall  survival.
Although  surgical  morbidity  must  certainly  be  taken  into
ccount,  the  morbidity  of  radioiodine  therapy  although  rare,
ust  also  not  be  ignored.  Precise  lymph  node  staging  can
herefore  allow  better  selection  of  patients  likely  to  beneﬁt
rom  adjuvant  radioiodine  therapy.
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